Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

MLA

Kociol, Robb D., et al. “Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims.” Circulation. Heart Failure, vol. 4, no. 5, Sept. 2011, pp. 628–36. EBSCOhost, https://doi.org/10.1161/CIRCHEARTFAILURE.111.962290.

APA

Kociol, R. D., Horton, J. R., Fonarow, G. C., Reyes, E. M., Shaw, L. K., O’Connor, C. M., Felker, G. M., & Hernandez, A. F. (2011). Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circulation. Heart Failure, 4(5), 628–636. https://doi.org/10.1161/CIRCHEARTFAILURE.111.962290

Chicago

Kociol, Robb D, John R Horton, Gregg C Fonarow, Eric M Reyes, Linda K Shaw, Christopher M O’Connor, G Michael Felker, and Adrian F Hernandez. 2011. “Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims.” Circulation. Heart Failure 4 (5): 628–36. doi:10.1161/CIRCHEARTFAILURE.111.962290.